Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19
Clinical trial NCT04619706 · TERMINATED
Trial details
- NCT number
- NCT04619706
- Sponsor
- Quantum Biopharma
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-14
- Primary completion
- 2021-08-24
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.